Riskpilot← Back to searchSign inGet full accessEdan Medicin AB
ABActiveOrg 5593729949Tellusgatan 5 1302General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2025
SEK -1
EBITDA margin
1478700.0%
+50% vs 2024
Equity ratio
94.6%
Financial strength
Net profit 2025
SEK -15K
+49% vs 2024
| Revenue | SEK -1 | — |
| EBITDA | SEK -15K | +50% |
| Net profit | SEK -15K | +49% |
| Total assets | SEK 69K | -23% |
| Equity | SEK 65K | -19% |
| Employees | 0 | — |
Legal name
Edan Medicin AB
Org number
5593729949
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 mars 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom medicinsk vård och konsultation, även yrkesutövning inom kosmetik och därmed förenlig verksamhet. Den medicinska vården kommer bedrivas genom konsultläkartjänster inom öppen- samt slutenvård. Vidare kommer bolaget satsa på att bedriva hälsoinriktade- och kosmetisktinriktade behandlingar samt affärsutvecklingar inom dessa områden.
Address
Tellusgatan 5 1302
Email
heddia.al-h@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 48 | 97 | 0 | −0 |
| Staff expenses | — | −3 | −0 | −0 |
| EBITDA | 47 | 63 | −30 | −15 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 47 | 63 | −30 | −15 |
| Net financials | 0 | 0 | −0 | −0 |
| Profit before tax | 47 | 63 | −30 | −15 |
| Tax | −10 | −15 | — | — |
| Net profit | 38 | 48 | −30 | −15 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 85 | 161 | 89 | 69 |
| Equity | 63 | 110 | 81 | 65 |
| Long-term debt | — | — | — | — |
| Short-term debt | 22 | 51 | 9 | 4 |
| Total debt | 22 | 51 | 9 | 4 |
EBITDA margin
-1478700.0%
This company
15.8%
Market median
-9358961% vs market
20222025
Equity ratio
94.6%
This company
38.2%
Market median
+148% vs market
20222025
Return on equity
-23.3%
This company
18.4%
Market median
-227% vs market
20222025
Net profit margin
-1522400.0%
This company
8.1%
Market median
-18795162% vs market
20222025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-29 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Edan Medicin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mnat-M Edan | Deputy Board Member | 0 companies |
| Heddia Edan | Board of Directors | 0 companies |